Rollover Study Of Lapatinib In Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms, Breast
Interventions: DRUG: GW572016 oral tablets
Sponsor: GlaxoSmithKline